Table 2 Distribution of serotype and alp genes among urinary GBS isolates across resistant isolates
Serotype | No. of resistant isolates (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Penicillin n = 8 (%) | Erythromycin n = 52 (%) | Clindamycin n = 47 (%) | Tetracycline n = 95 (%) | Vancomycin n = 1 (%) | Levofloxacin n = 9 (%) | Cefotaxime n = 8 (%) | Ceftriaxone n = 8 (%0 | Cefepime n = 8 (%) | |
Ia | – | 2 (3.8) | – | 4 (4.2) | – | 1 (11.1) | – | – | – |
Ib | 2 (25) | 22 (42.3)** | 23 (48.9)** | 24 (25.3) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
II | – | 3 (5.8) | 1 (2.1) | 7 (7.4) | – | 1 (11.1) | – | – | – |
III | 0* | 8 (15.4)** | 8 (17)** | 40 (42.1) | – | 0** | 0* | 0* | 0* |
IV | – | 2 (3.8) | 2 (4.3) | 1 (1.1)** | – | – | – | – | – |
V | 2 (25) | 12 (23.1) | 9 (19.1) | 16 (16.8) | – | 5 (55.6)** | 2 (25) | 2 (25) | 2 (25) |
NT | 4 (50)** | 3 (5.8) | 4 (8.5) | 3 (3.2) | 1 (100)** | 1 (11.1) | 4 (50)** | 4 (50)** | 4 (50)** |
alp gene | |||||||||
 rib | 1 (12.5) | 8 (15.4)** | 8 (17)** | 40 (42.1) | 1 (100) | 1 (11.1) | 1 (12.5) | 1 (12.5) | 1 (12.5) |
 alpha-c protein | 2 (25) | 20 (38.5)** | 21 (44.7)** | 22 (23.1) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
 alp 2/3 | – | 9 (17.3) | 9 (19.1) | 16 (16.8) | – | – | – | – | – |
 epsilon | 3 (37.5) | 12 (23.1)* | 5 (10.6) | 13 (13.7) | – | 6 (66.7)** | 3 (37.5) | 3 (37.5) | 3 (37.5) |
 alp4 | – | – | – | – | – | – | – | – | – |
 alpha-c protein + alp 2/3 | 2 (25)** | 2 (3.8) | 3 (6.4) | 3 (3.2) | – | 1 (11.1) | 2 (25) | 2 (25) | 2 (25) |
 alpha-c protein + rib | – | – | – | 0** | – | – | – | – | – |
 NT | – | 1 (1.9) | 1 (2.1) | 1 (1.1) | – | – | – | – | – |